Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin: a review on theoretical and experimental studies
Open Access
- 26 April 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 6 (16) , 3992-4014
Abstract
Effect of Doxorubicin on cancer cells.Keywords
Funding Information
- Anusandhan National Research Foundation (CRG/2020/006330)
This publication has 106 references indexed in Scilit:
- Investigation of interactions of doxorubicin with purine nucleobases by molecular modelingJournal of Molecular Modeling, 2022
- Surface Functionalization of Graphene‐Based Materials: Biological Behavior, Toxicology, and Safe‐By‐Design AspectsAdvanced Biology, 2021
- Doxorubicin-loaded biodegradable chitosan–graphene nanosheets for drug delivery applicationsPolymer Bulletin, 2021
- Pulmonary Targeting Crosslinked Cyclodextrin Metal–Organic Frameworks for Lung Cancer TherapyAdvanced Functional Materials, 2020
- Superparamagnetic graphene oxide/magnetite nanocomposite delivery system for doxorubicin-induced distinguished tumor cell cycle arrest and apoptosisJournal of Nanoparticle Research, 2020
- Understanding the In Vivo Fate of Advanced Materials by ImagingAdvanced Functional Materials, 2020
- Synthesis, characterization, and interactions of single-walled carbon nanotubes modified with doxorubicin with Langmuir–Blodgett biomimetic membranesJournal of Nanoparticle Research, 2018
- Accumulation and toxicity of intravenously‐injected functionalized graphene oxide in miceJournal of Applied Toxicology, 2015
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- Physical Chemistry of Macromolecules2004